SCHEMBL19689331

SCHEMBL19689331

CC(CCc1nc2ccc(Br)cc2s1)(C(=O)NOC1CCCCO1)S(C)(=O)=O

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
ALDH1A1 P00352 1/20 0.35
CCNA2 P20248 1/20 0.35
CDK2 P24941 1/20 0.35
CCNA1 P78396 1/20 0.35
CDK5 Q00535 1/20 0.35
CDK5R1 Q15078 1/20 0.35
RAB9A P51151 2/20 0.35
ACACB O00763 1/20 0.35
NPC1 O15118 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
DYRK1A Q13627 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21458053 1.00 CA12 (0.36) CA12CA1CA2CA9ALDH1A1
SCHEMBL19615713 0.89 CCNA2 (0.35) ALDH1A1CCNA2CDK2CCNA1CDK5
SCHEMBL19615715 0.89 CCNA2 (0.35) ALDH1A1CCNA2CDK2CCNA1CDK5
SCHEMBL19689327 0.86
SCHEMBL21458094 0.83 KDM4E (0.31) ALDH1A1CCNA2CDK2CCNA1CDK5
SCHEMBL19616218 0.83 KDM4E (0.31) ALDH1A1CCNA2CDK2CCNA1CDK5
SCHEMBL19689318 0.82 CCNA2 (0.30) CCNA2CDK2CCNA1CDK5CDK5R1
SCHEMBL20815754 0.82 CCNA2 (0.30) CCNA2CDK2CCNA1CDK5CDK5R1
SCHEMBL19616283 0.82 KDM4E (0.30) ALDH1A1CCNA2CDK2CCNA1CDK5
SCHEMBL19616284 0.82 KDM4E (0.30) ALDH1A1CCNA2CDK2CCNA1CDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190315731-A1 6-(BUTA-1,3-DIYN-1-YL)BENZO[D]THIAZOLE DERIVATIVES ACTELION PHARMACEUTICALS, LTD. (CH) 2019-10-17 US disclosed
EP-3221300-B1 ANTIBACTERIAL BENZOTHIAZOLE DERIVATIVES IDORSIA PHARMACEUTICALS LTD (CH) 2019-03-20 EP disclosed
US-20170355687-A1 ANTIBACTERIAL BENZOTHIAZOLE DERIVATIVES IDORSIA PHARMACEUTICALS LTD (CH) 2017-12-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190315731-A1 6-(BUTA-1,3-DIYN-1-YL)BENZO[D]THIAZOLE DERIVATIVES TMBIM6, BTN3A1, BET1 CA12 4602/4885CA1 4197/4885CA2 2285/4885
US-20170355687-A1 ANTIBACTERIAL BENZOTHIAZOLE DERIVATIVES CYP8B1, TUBB, DRD3 CA12 4673/4885CA1 4577/4885CA2 3029/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.